Literature DB >> 27081135

Complete Genome Sequence of Mycoplasma mycoides subsp. mycoides T1/44, a Vaccine Strain against Contagious Bovine Pleuropneumonia.

Géraldine Gourgues1, Aurélien Barré2, Emmanuel Beaudoing3, Johann Weber3, Ghislaine Magdelenat4, Valérie Barbe4, Elise Schieck5, Joerg Jores6, Sanjay Vashee7, Alain Blanchard1, Carole Lartigue1, Pascal Sirand-Pugnet8.   

Abstract

Mycoplasma mycoidessubsp.mycoidesis the etiologic agent of contagious bovine pleuropneumonia. We report here the complete genome sequence of the strain T1/44, which is widely used as a live vaccine in Africa.
Copyright © 2016 Gourgues et al.

Entities:  

Year:  2016        PMID: 27081135      PMCID: PMC4832163          DOI: 10.1128/genomeA.00263-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Contagious bovine pleuropneumonia (CBPP) is considered by the World Organization for Animal Health as one of the most severe animal diseases affecting cattle in sub-Saharan Africa. As a consequence, CBPP has a major impact on livestock-dependent people, causing reduced food supply and significant income losses because of trade restrictions. Several vaccine strains have been developed so far from the causative agent Mycoplasma mycoides subsp. mycoides, including strain T1/44, which is currently used in Africa. This attenuated strain was derived in the 1950s from a Tanzanian strain by 44 passages on embryonated eggs (1). The T1/44 strain provides partial protection to the vaccinated animals. However, it can still cause disease when applied directly into the lungs (2), indicating a retained virulence potential. Here, we present the complete genome sequence of this important veterinary live vaccine strain. The culture used for gDNA extraction was the CIRAD-EMVT/PANVAC CBPP vaccine strain T1/44/2 (batch EMVT 002, June 1996), as stored in the collection maintained at Anses, Lyon’s laboratory, under the reference number 11278. This strain was grown at 37°C as previously described (3), and gDNA was extracted with the QiagenMagAttractHMW kit (100 to 200 kb) and quality-controlled by gel electrophoresis and a quantification by fluorescence. The T1/44 genome was sequenced on a PacBio RSII sequencer at the Lausanne Genomic Technologies Facility. Its genome was assembled into one single contig using the HGAP version 3.0 (4) and toAmos (5) assembly software. Genome annotation was performed using Prokka (6) and further improved manually after integration in the MolliGen database (http://www.molligen.org) (7). The genome of Mycoplasma mycoides subsp. mycoides T1/44 consists of a 1,188,848-bp chromosome with a G+C content of 23.92% and encoded 1,112 coding sequences, 2 rRNA sets, and 30 tRNAs. Its genome organization is very similar to the previously sequenced reference strain PG1 (8) (GenBank accession no. BX293980), except for an inversion of 173 kb between two IS-rich loci. This remarkable inversion (positions 1,173,545 to 1,188,848 and 1 to 157,822) includes the predicted chromosomal replication origin and was confirmed by optical mapping using the Argus system (OpGen) and PvuII as restriction enzyme. Interestingly, the T1-specific PCR assay developed previously by others is based on two primers, MmmSCP1 and T1M2, that are complementary to each side of the upstream junction. Therefore, the T1/44 genome sequence provides the explanation for the specificity of this assay with the ability to distinguish T1 strains from other vaccine strains (9).

Nucleotide sequence accession number.

The annotated genome sequence was deposited in GenBank under accession number CP014346.
  8 in total

1.  Specific PCR identification of the T1 vaccine strains for contagious bovine pleuropneumonia.

Authors:  S Lorenzon; A David; M Nadew; H Wesonga; F Thiaucourt
Journal:  Mol Cell Probes       Date:  2000-08       Impact factor: 2.365

2.  MolliGen, a database dedicated to the comparative genomics of Mollicutes.

Authors:  Aurélien Barré; Antoine de Daruvar; Alain Blanchard
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

3.  Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data.

Authors:  Chen-Shan Chin; David H Alexander; Patrick Marks; Aaron A Klammer; James Drake; Cheryl Heiner; Alicia Clum; Alex Copeland; John Huddleston; Evan E Eichler; Stephen W Turner; Jonas Korlach
Journal:  Nat Methods       Date:  2013-05-05       Impact factor: 28.547

4.  Prokka: rapid prokaryotic genome annotation.

Authors:  Torsten Seemann
Journal:  Bioinformatics       Date:  2014-03-18       Impact factor: 6.937

5.  Next generation sequence assembly with AMOS.

Authors:  Todd J Treangen; Dan D Sommer; Florent E Angly; Sergey Koren; Mihai Pop
Journal:  Curr Protoc Bioinformatics       Date:  2011-03

6.  The genome sequence of Mycoplasma mycoides subsp. mycoides SC type strain PG1T, the causative agent of contagious bovine pleuropneumonia (CBPP).

Authors:  Joakim Westberg; Anja Persson; Anders Holmberg; Alexander Goesmann; Joakim Lundeberg; Karl-Erik Johansson; Bertil Pettersson; Mathias Uhlén
Journal:  Genome Res       Date:  2004-02       Impact factor: 9.043

7.  Contagious bovine pleuropneumonia (CBPP) caused by vaccine strain T1/44 of Mycoplasma mycoides subsp. mycoides SC.

Authors:  Rosa-Stella Mbulu; Georgina Tjipura-Zaire; Rosella Lelli; Joachim Frey; Paola Pilo; Edy M Vilei; Felix Mettler; Robin A J Nicholas; Otto J B Huebschle
Journal:  Vet Microbiol       Date:  2004-03-05       Impact factor: 3.293

8.  The flavoprotein Mcap0476 (RlmFO) catalyzes m5U1939 modification in Mycoplasma capricolum 23S rRNA.

Authors:  Carole Lartigue; Anne Lebaudy; Alain Blanchard; Basma El Yacoubi; Simon Rose; Henri Grosjean; Stephen Douthwaite
Journal:  Nucleic Acids Res       Date:  2014-06-17       Impact factor: 16.971

  8 in total
  1 in total

1.  Reproduction of contagious caprine pleuropneumonia reveals the ability of convalescent sera to reduce hydrogen peroxide production in vitro.

Authors:  Anne Liljander; Flavio Sacchini; Michael H Stoffel; Elise Schieck; Nadine Stokar-Regenscheit; Fabien Labroussaa; Martin Heller; Jeremy Salt; Joachim Frey; Laurent Falquet; Danny Goovaerts; Joerg Jores
Journal:  Vet Res       Date:  2019-02-08       Impact factor: 3.683

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.